The antiviral drug remdesivir had no substantial impact on the survival of COVID-19 patients or the length of their hospital stays, according to a World Health Organization (WHO) clinical trial. More
This Viewpoint proposes that sensible medicine for COVID-19 may better serve patients than unreasoned treatment using unproven interventions in the moment. More
A grim reality is setting in across the U.S. hospital sector: a surge in coronavirus infections is encroaching while most facilities are still recovering from the onset of the pandemic. More
Javaid Perwaiz, a former OB/GYN, faces trial this week in Norfolk, Va. He is charged with health-care fraud. More
A study late last week found that convalescent plasma (CP) treatment did not significantly reduce mortality, but improved hospital discharge rates for patients 65 and older. More
This Viewpoint proposes that varying combinations of evidence, physician influence, and economics guide the continuation or de-adoption of low-value health services and can help organize and prioritize policy initiatives to drive down the prevalence of wasteful care. More
Bronchiolitis is one of the most common reasons for pediatric hospitalization in the United States, incurring costs of $734 million each year. More
An insurer-led experiment adds community pharmacists to care teams in the hope of controlling chronic conditions and reducing hospital readmissions. More
This week, former Harvard Medical School professor William Haseltine wrote, “Beware of COVID-19 vaccine trials designed to succeed from the start.” More
With several Covid-19 vaccines in hand, we will need to a trial to know which are most effective at preventing the disease, or safest. More